About this episode
Episode 2 explores how private‑practice and industry‑run clinical trials bring efficiency, flexibility, and broader patient access to the research landscape. Our guests discuss the financial and scientific motivations behind industry partnerships, the strengths and trade‑offs of private sites, and how these settings support large, fast‑moving studies. Rare‑disease trials, PK designs, and investigator‑initiated research are highlighted as key collaborative touchpoints.
This independent medical education program is supported by Incyte.
Please click here for a complete list of disclosures.
Get every episode summarized
Each time PeDRA Pearls publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from PeDRA Pearls
Bridging the Lab and the Bedside: The Science Behind Severe Skin Reactions
PeDRA Pearls
Spring Forward with PeDRA: Key Deadlines & Opportunities
PeDRA Pearls
More Than Hair: Quality of Life After Persistent Alopecia
PeDRA Pearls
Points of Discussion: Clinical Trials - Academic Clinical Trials and How they Wo...
PeDRA Pearls